Home /Research /Abstracts

Abstracts

PDF Year Authors Title Conference
  2015 Edén A, Franklin D, Zetterberg H, Nilsson S, Fuchs D, Heaton RK, Letendre S, Marcotte T, Price RW, Grant I, Gisslén M. CNS Immuactivation and neuronal damage in patients with progressive neurocognitive impairment. Conference on Retroviruses and Opportunistic Infections. 
  2015 Anderson AM, Fennema-Notestine C, Umlauf A, Clifford DB, Marra CM, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Letendre S, for the CHARTER Group. CSF biomarkers correlate with magnetic resonance spectroscopy metabolites during HIV disease. Conference on Retroviruses and Opportunistic Infections. 
2015 Kallianpur A, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan J, Bush W, Heaton R, Samuels D, Franklin D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Grant I, Simpson D, and Hulgan T, for the CHARTER Group. CSF biomarkers of iron transport and angiogenesis are associated with HAND. 13th International Symposium on NeuroVirology.
2015 Oliveira M, Murrell B, Perez-Santiago J, Vargas M, Ellis R, Letendre S, Grant I, Smith D, Woods S, Gianella S. HIV DNA and neurocognitive impairment in older subjects on suppressive ART. Conference on Retroviruses and Opportunistic Infections.
2015 Thornton-Wells T, Fennema-Notestine C, Hulgan T, Letendre S, Ellis R, Kallianpur A, for the CHARTER Group. Iron-Regulatory genes are associated with neuroimaging traits in HIV infection. Conference on Retroviruses and Opportunistic Infections.
  2015 Fazeli P, Moore DJ, Franklin DR, Heaton RK, Marra C, Gelman B, McCutchan JA, Grant I, Letendre S, for the CHARTER Group.  Lower CSF Amyloid-β levels are associated with worse neurocognitive functioning in HIV-infected adults with a family history of dementia. Conference on Retroviruses and Opportunistic Infections.
  2015 Hulgan T, Samuels D, Ellis R, Bush W, Letendre S, Franklin D, Grant I, Kallianpur A. Mitochondrial DNA haplogroups and CSF neuroinflammation in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
2015 Pérez-Santiago J, De Oliveira MF, Murrell B, Var S, Day T, Woods S, Ellis R, Gianella S, Mehta S. Mitochondrial DNA, neurologic and systemic inflammation, and immune dysregulation. Conference on Retroviruses and Opportunistic Infections.
  2015 Marquine M. Neurocognitive decline in HIV-infected Hispanics: Rates and predictors. 43rd Annual Meeting of the International Neuropsychological Society.
2015 Moore D, Fazeli P, Casaletto K, Letendre S, Scott J, Woods S, Jeste D, Grant I, and the HNRP Group. Neuropsychological functioning is associated with multitasking in older HIV+ adults. 43rd Annual Meeting of the International Neuropsychological Society.
  2015 Brouillette MJ, Yuen T, Scott SC, Fellows LK, Heaton R, Letendre S, Ellis RJ, Mayo N. Predictors of neurocognitive decline among aviremic individuals in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
2015 Yek C, Smith DM, Wagner GA, Morgello S, Letendre S, Grant I, Kosakovsky Pond SL, Gianella S, the CHARTER Study Group. Suppressive ART is key to reduce neurocognitive impairment in aging HIV+ individuals. Conference on Retroviruses and Opportunistic Infections.
2015 Singh K, Deng Q, Fennema-Notestine C, Vaida F, Ellis RJ, Letendre SL, Franklin D, Rosario D, Heaton RD, Grant I, and CHARTER Group. Synergistic effects of MBL2/APP polymorphisms on neurocognitive impairment in CHARTER. Conference on Retroviruses and Opportunistic Infections.
2014 Sattler F, He J, Letendre S, Wilson C, Fitzsimmons C, Heaton R, Ellis R, Franklin D, Grant I, McCutchan A, for the CHARTER Group. Abdominal obesity, inflammation, immune activation and neurocognitive impairment in HIV. Conference on Retroviruses and Opportunistic Infections.
2014 Kallianpur A, Wang Q, Jia P, McArthur JC, Morgello S, Collier AC, Gelman BB, Clifford DB, McCutchan JA, Grant I, and the CHARTER Study Group. Blood Cell Indices and Neurocognitive Impairment in the HAART Era: a CHARTER Study. Conference on Retroviruses and Opportunistic Infections.
2014 Pérez-Valero I, Letendre S, Heaton R, Ellis R, MCCutchan A, Simpson D, Deutsch R, Grant I, and the CHARTER Group. CSF biomarker profile in HIV patients with and without CSF viral escape. Conference on Retroviruses and Opportunistic Infections.
2014 Anderson AM, Fennema-Notestine C, Umlauf A, Clifford D, Marra C, Gelman B, McArthur J, McCutchan A, Morgello S, and Letendre S, for the CHARTER group. CSF biomarkers correlate with magnetic resonance spectroscopy metabolites during HIV disease. Conference on Retroviruses and Opportunistic Infections.
2014 Wagner GA, Chaillon A, Franklin DR, Caballero G, Kosakovsky Pond SL, Heaton RK, Richman DD, Smith D, and the CHARTER Group. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. Conference on Retroviruses and Opportunistic Infections.
  2014 Marquine MJ, Moore DJ, Cherner M, Ellis R, Deutsch R, Franklin D, Letendre S, Collier A Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Heaton RK, Grant I and the CHARTER Group. HIV-infected Hispanics are at increased risk for neurocognitive impairment. UCSD 9th Annual Lewis L. Judd Young Investigators Research Symposium. 
2014 Pérez-Valero I, Heaton R, Franklin D, Letendre S, Deutsch R, Gelman B, Simpson D, Collier A, Grant I, and the CHARTER Group. HIV-replication control rates needed to prevent neurocognitive performance (NP) decline. Conference on Retroviruses and Opportunistic Infections. 
  2014 Gelman BB, Ahuja S, Ellis R, Letendre S, Marra C, McArthur J, Morgello S, Clifford D, Grant I, Vaida F. HLA gene loci associated with HIV load in csf and blood plasma in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
2014 Singh K, Vaida F, Fennema-Notestine C, Ellis R, Letendre S, Franklin D, Deng Q, Rosario D, Corkran S, Heaton R, Grant I, and CHARTER Group. MBL2 promoter polymorphism rs7096206 predicts brain metabolite anomalies in HIV-infected adults. Conference on Retroviruses and Opportunistic Infections.
2014 Hulgan T, Samuels D, Bush W, Ellis R, Letendre S, Straub P, Murdock D, Franklin D, Grant I, Kallianpur A, for the CHARTER Group. Mitochondrial DNA haplogroups and neurocognitive impairment in the CHARTER Cohort. Conference on Retroviruses and Opportunistic Infections.
  2014 Pérez-Santiago J, Mehta SR, Gianella S, Schrier R, Cherner M, Var SR, Day TRC, Ramirez-Gaona M, Smith DM and Letendre S. Mitochondrial DNA is associated with inflammation and neurocognitive deficits in HIV infection. Conference on Retroviruses and Opportunistic Infections.
2014 Heaton R, Franklin D, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine M, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group. Neurocognitive change in the era of HIV combination antiretroviral therapy: A CHARTER Study. International AIDS Conference.
  2014 Edén A, Franklin D, Fuchs D, Grant I, Letendre S, Marcotte T, Nilsson S, Price RW, Zetterberg H, Gisslén M, for the CHARTER group. Normal cerebrospinal fluid neurofilament light protein, but increased intrathecal immunoactivation in virally-suppressed HIV-infected patients with mild neurocognitive impairment. Conference on Retroviruses and Opportunistic Infections.
  2014 Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, McArthur JC, for the CHARTER Group. Persistent csf, but not plasma HIV RNA is associated with Increased risk of new-onset depression. Conference on Retroviruses and Opportunistic Infections.
2014 Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, McArthur JC, for the CHARTER Group. The Cerebrospinal Fluid HIV Risk Score for assessing central nervous system HIV activity. Conference on Retroviruses and Opportunistic Infections.
  2013 Singh K, Vaida F, Fennema-Notestine C, Ellis R, Letendre S, Franklin D, Deng Q, Rosario D, Heaton R, Grant I, and the CHARTER Group. A loss of function Polymorphism in complement Factor H predicts HIV-1 related neurocognitive impairment and neuroimaging abnormalities. Conference on Retroviruses and Opportunistic Infections.
2013 Keltner JR, Connolly CG, Vaida F, Franklin DR, FitzSimons C, Corkran S, Grant I, Atkinson JH, Ellis RJ. HIV-associated distal neuropathic pain is associated with smaller ventral posterior cingulate cortex. Scientific Meeting of the American Pain Society
  2013 Ellis R, Iudicello J, Marquine M, Ghias A, Heaton R, Kao Y, Deutsch R, McCutchan JA. Impact of metabolic syndrome and vascular risk factors on age-related neurocognitive decline in HIV. International Workshop on HIV and Aging.
2013 Perez-Valero I, Letendre S, Deutsch R, Heaton R, Clifford DB, McArthur J, Morgello S, Gelman B, Collier A, Grant I, the CHARTER Group, and the HNRP Group. Incidence, risk factors and neurocognitive impact of CSF viral escape: Longitudinal analysis of the CHARTER & HNRP Cohorts. Conference on Retroviruses and Opportunistic Infections.
2013 Letendre S, Vaida F, Wong S, Croteau D, FitzSimons C, Grant I, Ellis R. Long-term efavirenz use is associated with worse neurocognitive functioning. Conference on Retroviruses and Opportunistic Infections.
2013 Letendre S, McClernon D, Deutsch R, Cherner M, Cookson, Crescini M, Grant I, Ellis R. Low-level HIV RNA declines over time in csf but not in plasma. Conference on Retroviruses and Opportunistic Infections.
2013 Ghias A, Marquine M, Kao Y, Deutsch R, Fazeli P, Iudicello J, Riggs K, Franklin D, Heaton RK, Hong S, McCutchan JA, Grant I, Ellis RJ. Metabolic syndrome and vascular risk factors impact neurocognitive decline in HIV. Meeting of the American Neurological Association.
2013 Fennema-Notestine C, Taylor MJ, Notestine RJ, Wolfson T, Gamst AC, Archibald SL, Theilmann RJ, Heaton RK, Marra C, Grant I, for the CHARTER Group. Neuroimaging correlates of prior immunosuppression and cognitive status in HIV. Conference on Retroviruses and Opportunistic Infections.
  2013 Heaton RK, Letendre S, Collier A, Clifford D, Gellman B, Marra C, Morgello S, McArthur J, McCutchan A, Simpson D, Franklin D, Grant I, for the CHARTER Group. Overview of HIV Associated Neurocognitive Disorders (HAND): Findings from the Six-Site CNS HIV Anti-Retroviral Effects Research (CHARTER). Mid-Year Meeting International Neuropsychological Society.
  2013 McCutchan JA, Marquie-Beck J, Fitzsimons C, Letendre S, Ellis R, Heaton R, Wolfson T, Marra C, Ances B, Grant I, and the CHARTER Group. Role of central obesity, diabetes, and metabolic variables in HIV-associated neurocognitive disorders. Conference on Retroviruses and Opportunistic Infections. 
2013 Franklin D, Heaton R, Woods S, Letrendre S, Collier A, Clifford D, Gelman B, McArthur J, Simpson J, Grant I. Veterans Aging Cohort Study (VACS) index score are associated with cognition and HAND symptoms: A CHARTER Study. Conference on Retroviruses and Opportunistic Infections. 
  2012 Ellis R, Letendre SL, Rosario D, Gelman B, Clifford D, Simpson D, McArthur J, Marra C, McCutchan JA, Grant I, for the CHARTER Group. A common polymorphism in the COMT gene confers an increased risk of neuropathic pain in HIV sensory neuropathy. American Academy of Neurology. 
  2012 Letendre S, Marcotte T, Deutsch R, Franklin D, Rosario D, Alexander T, Haughey N, Pardo C, Fox H, Grant I. A concise panel of biomarkers diagnoses and predicts neurocognitive (NC) status in HIV-Infected individuals. Conference on Retroviruses and Opportunistic Infections. 
2012 Haughey N, Mielke M, Bandaru V, Sacktor N, Grant I, Letendre S, Fox H, Chang L, Wozna V, Pardo C, McArthur J. A lipidomic analysis of CSF from HIV-infected subjects identifies metabolites that predict change in cognitive performance. Conference on Retroviruses and Opportunistic Infections.
2012 Heaton R, Franklin D, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Smith D, Collier A, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan A, Grant I, for the CHARTER Group. Aging amplifies HIV neurocognitive impairment: The effects may be related to vascular and metabolic factors. Journal of NeuroVirology, 18(Suppl 1), S46. 
  2012 Heaton R, Franklin D, Woods S, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, McCutchan A, and Grant I. Asymptomatic mild HIV-associated neurocognitive disorder increases risk for future symptomatic decline: A CHARTER longitudinal study. Conference on Retroviruses and Opportunistic Infections.
2012 Blackstone K, Moore DJ, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Ellis RJ, Atkinson JH, Grant I, Heaton RK, for the CHARTER Group. Deficit scores versus clinical ratings: Defining neurocognitive impairment in HIV. Meeting of the International Neuropsychological Society
2012 Ferrara M, Umlauf A, FitzSimons C, Meyer J, Duarte N, Atkinson JH, Grant I, Ellis R, for the CHARTER Group. Effect of second generation antipsychotics on metabolic variables in HIV-infected adults on long term antiretroviral therapy. International AIDS Conference.
  2012 Burdo T, Weiffenbach A, Woods S, Letendre L, Ellis R, Williams K. Elevated sCD163 in NP impaired HIV+ individuals despite virally suppressive ART. Conference on Retroviruses and Opportunistic Infections.
2012 Choi JY, Heaton R, Grant I, Marcotte T, Ellis R, Letendre R, Marra C, Clifford D, Richman D, Smith D, and the CHARTER Group. Genetic features of cerebrospinal fluid-derived subtype B HIV-1tat. Conference on Retroviruses and Opportunistic Infections.
2012 Letendre S, Bharti A, Perez Valero I, Landay A, Hanson, Franklin D, Woods S, Heaton R, Grant I, Lurain N, for the CHARTER Group. Higher ctomegalovirus (CMV) antibody concentrations are associated with older age, lower nadir CD4+ cell counts, and worse global neurocognitive (NC) functioning in people with HIV disease. Conference on Retroviruses and Opportunistic Infections.
2012 Blackstone K, Moore DJ, Woods SP, Morgan EE, Franklin DR, Ellis RJ, Letendre SL, Grant I, Heaton RK, and the CHARTER Group. How "asymptomatic" is HIV-associated asymptomatic neurocognitive impairment? Conference on Retroviruses and Opportunistic Infections.
2012 Letendre SL, Vaida F, Ellis R, Clifford D, Gelman B, Marra C, McArthur J, McCutchan A, Simpson D, Grant I, and the CHARTER Group. Longitudinal correlates of HIV RNA levels in 2,207 CSF specimens. Conference on Retroviruses and Opportunistic Infections.
2012 Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Alexander T, Morgan EE, Woods S, Collier A, Clifford D, Gelman B, McCutchan A, McArthur J, Morgello S, Grant I, and the CHARTER Group. Norms and alternative cutpoints improve sensitivity/specificity tradeoff for the HIV Dementia Scale: The CHARTER study. Meeting of the International Neuropsychological Society.
2012 Croteau D, Letendre S, Best B, Clifford D, Gelman B, Marra C, McArthur J, McCutchan JA, Simpson D, Grant I. Older age is associated with higher antiretroviral concentrations in cerebrospinal fluid in HIV-infected individuals. Conference on Retroviruses and Opportunistic Infections.
2012 Heaton R, Deutsch R, Franklin D, Woods S, Collier A, Clifford D, Gelman B, McArthur J, Simpson D, Grant I, for the CHARTER Group. Prevalence and predictors of neurocognitive decline over 18 to 42 months: A CHARTER longitudinal study. Conference on Retroviruses and Opportunistic Infections.
2012 Pérez-Valero I, Letendre S, Ellis R, Deutsch R, Franklin D, Clifford DB, Heaton R, McCutchan J, McArthur J, Morgello S, Gelman B, Collier A, Grant I, and the CHARTER & HNRP Groups. Prevalence and risk factors for HIV CSF viral escape: Results from the CHARTER and HNRP cohorts. International Congress on Drug Therapy.
2012 McCutchan JA, Marquie-Beck J, FitzSimons C, Letendre S, Ellis RJ, Heaton R, Wolfson T, Marra C, Ances B, Grant I, for the CHARTER Group. Role of central obesity, diabetes, and metabolic variables in HIV-associated neurocognitive disorder. Conference on Retroviruses and Opportunistic Infections.
2012 Ellis R, Gelman B, Letendre S, Clifford D, Marra C, McArthur J, McCutchan J,Simpson D, Grant I, and the CHARTER Group. Soluble CD14 in cerebrospinal fluid in HIV sensory neuropathy. Conference on Retroviruses and Opportunistic Infections.
2012 Perez-Valero I, Heaton R, Letendre S, McCutchan J, Morgello S, Gelmen B, Collier A, Grant I, and the CHARTER Group. Validation of the EACS guidelines 2011 algorithm for detecting HAND in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
2012 Cushman C, Gamst A, Yamada L, Ellis R, Alexander T, Grant I. Web-based collection of antiretroviral medication histories. International Symposium on NeuroVirology.
  2011 Clifford D, Morgan E, Vaida F, Heaton R, Goate A, Bloss C, Marra C, Ances B, Collier A, Gelman B, McArthur J, Morgello S, Letendre S, Grant I, for the CHARTER Study. APOE Genotype is not related to Neurocognitive Function in HIV: CHARTER Analysis. IAS Conference on HIV Pathogenesis, Treatment and Prevention.
  2011 Keltner JR, Vaida F, Ellis R, Moeller-Bertram T, Franklin D, FitzSimons C, Corkran S, Duarte N, Robinson-Papp J, Dworkin R, Clifford D, Gelman B, Simpson D, McArthur J, Mccuthan A, Collier A, Marra C, Morgello S, Atkinson J, Grant I, for the CHARTER Group. Depression is associated with more functional impairment than distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. American Pain Society’s Annual Scientific Meeting.
  2011 Blackstone K, Moore DJ, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McARthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Deutsch R, Ellis RJ, Atkinson JH, Hetaon RK, Grant I. Diagnosing symptomatic HIV-associated cognitive disorders: Self-report versus performance-based assessment everyday functioning. IAS Conference on HIV Pathogenesis, Treatment and Prevention.
2011 Holzinger E, Hulgan T, Ellis R, Samuels D, Clifford D, Collier A, Gelman B, Morgello S, Letendre S, Grant I, and the CHARTER Group. Full sequence mtDNA variation and HIV-SN in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
  2011 Hightower G, Wong J, Letendre S, Umlauf A, Ellis R, Ignacio C, Heaton R, Grant I, Richman D, Smith D, and the CHARTER Group. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Conference on Retroviruses and Opportunistic Infections.
2011 Heaton R, Franklin D, Ellis RJ, Letendre S, LeBlanc S, Woods SP, Clifford D, Rivera-Mindt M, Taylor M, Marcotte T, Atkinson JH, Collier A, Marra CM, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER and HNRC Groups. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy. Neuropsychological Society Annual Meeting.
2011 Kallianpur A, Ellis R, Marra C, Simpson D, McArthur J, Clifford D, Gelman B, McCutchan A, Letendre S, Grant I, and the CHARTER Group. Impact of genetic variation in iron transport pathways on neuropathy morbidity during ART: Results from the CHARTER Genome-wide Study. Conference on Retroviruses and Opportunistic Infections.
  2011 Fennema-Notestine C, Letendre SL, Archibald SL, Jernigan TL, Ellis RJ, Taylor MJ, Theilmann RJ, Julaton ML, Croteau D, Wolfson T, Heaton RK, Gamst AC, Franklin DR, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, for the CHARTER Group. Increasing CD4 levels are associated with more white matter abnormalities and increased gray matter over time in HIV: The CHARTER Study. International Meeting on HIV Infection and the Central Nervous System.
2011 Letendre S, Croteau D, Ellis R, Clifford D, Gelman B, Marra C, McArthur J, McCutchan A, Simpson D, Grant I, and the CHARTER Group. Lower CSAR are associated with global neurocognitive impairment in antiretroviral-treated people with HIV. Conference on Retroviruses and Opportunistic Infections.
2011 Marra C, Deutsch R, Collier A, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan A, Grant I, and the CHARTER Group. Neurocognitive impairment in HIV-infected patients with past syphilis. Conference on Retroviruses and Opportunistic Infections.
2011 Archibald S, Fennema-Notestine C, McCutchan JA, FitzSimons C, Ances B, Wolfson T, Jernigan T, Ellis RJ, Collier A, McArthur J, Morgello S, Simpson D, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Neuroimaging correlates of metabolic variables in HIV: The CHARTER Study. International Meeting on HIV Infection and the Central Nervous System.
2011 Patton D, Woods SP, Franklin D, Heaton RK, Collier A, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER Group. Relationship of medication management test-revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. International Neuropsychological Society Annual Meeting.
2011 Best B, Letendre S, Croteau D, Capparelli E, Clifford D, Gelman B, Marra C, McArthur J, Simpson D, Grant I, and the CHARTER Group. Therapeutic DRV and ETR concentrations in CSF. Conference on Retroviruses and Opportunistic Infections.
  2011 Ellis RJ, FitzSimons C, McArthur JC, Polydefkis M, Clifford D, Simpson D, Gelman BB, Morgello S, Collier A, Marra C, McCutchan JA, Grant I. Virologic suppression enhances epidermal nerve fiber recovery in HIV infection. IAS Conference on HIV Pathogenesis, Treatment and Prevention.
2011 Moore DJ, Letendre SL, Deutsch R, Little S, Smith D, Morris S, Franklin DR, Gouaux B, LeBlanc S, Rosario D, Heaton RK, Ellis R, Atkinson JH, Grant I, for the CHARTER Group. Acute and early HIV-infected persons evidence learning impairments. International Neuropsychological Society Annual Meeting.
  2010 Letendre SL, FitzSimons C, Ellis RJ, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Vaida F, Heaton R, Grant I, and the CHARTER Group. Correlates of CSF Viral Loads in 1,221 volunteers of the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections. 
2010 Letendre SL, Ellis RJ, Deutsch R, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Heaton R, Grant I, and the CHARTER Group. Correlates of time-to-loss-of-viral-response in CSF and plasma in the CHARTER Cohort. Conference on Retroviruses and Opportunistic Infections.
2010 Lin K, Taylor MJ, Heaton RK, Franklin D, Jernigan TL, Fennema-Notestine C, McCutchan A, Atkinson JH, McArthur J, Morgello Simpson D, Collier A, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV+ individuals. International Neuropsychological Society Annual Meeting.
2010 Moore DJ, Moseley S, McCutchan JA, Marquie-Beck JA, Frankiln DR, Vaida F, Achim C, Grant I, the CHARTER Group, the HNRC Group. Family history of dementia may increase risk for neuropsychological impairment among HIV infected persons. American Academy of Clinical Neuropsychology.
2010 Ellis RJ, Heaton RK, Letendre SL, Badiee J, Munoz-Moreno JA, Vaida F, Clifford DB, Gelman BB, Simpson DM, Grant I, for the CHARTER Group. Higher CD4 nadir is associated with reduced rates of HIV-associated neurocognitive disorders in the CHARTER Study: Potential implications for early treatment initiation. Conference on Retroviruses and Opportunistic Infections.
2010 Moore DJ, Letendre SL, Deutsch R, Little S, Smith D, Franklin DR, Rosario D, Heaton RK, Grant I, for the CHARTER Group. HIV-associated neurocognitive disorder (HAND) in acute and early HIV infection. Conference on Retroviruses and Opportunistic Infections.
2010 Heaton R, Franklin D, Ellis R, Letendre S, LeBlanc S, Woods S, Clifford D,Rivera Mindt M, Taylor M, Marcotte T, Atkinson JH, Collier A, Marra C, Gelman B, McArthur J, Morgello S,Simpson D, McCutchan JA, Grant I for the CHARTER and HNRC Groups. Increased rate of HIV neurocognitive impairment (NCI) among non-AIDS cases in the post-CART versus pre-CART era. International AIDS Conference.
2010 Fennema-Notestine C, Archibald SL, Notestine RJ, TaylorMJ, Theilmann RJ, Julaton M, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin, Jr. DR, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Jernigan TL, for the CHARTER Group. Increasing CD4 levels are associated with more white matter abnormalities and increased gray matter over time in HIV: The CHARTER Study. Society for Neuroscience Annual Meeting
2010 Croteau D, Best B, Letendre S, Rossi S, Ellis RJ, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Way L, Capparelli E, Grant I. Lower than expected Maraviroc concentrations in cerebrospinal fluid still exceed the 50% inhibitory concentration for wild-type CCR5-tropic HIV-1. International Society for NeuroVirology.
  2010 Ellis R, Badiee J, Letendre S, Vaida F, Franklin D, Heaton R, Clifford D, Collier A, Marra C, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER Group. Nadir CD4 is a predictor of HIV neurocognitive impairment (NCI) in the era of combination antiretroviral therapy: results from the CHARTER Study. International AIDS Conference.
2010 Al-Lozi M, Ellis R, Vaida F, FitzSimons C, McCutchan JA, McArthur J, Morgello S, Simpson D, Collier A, Marra C, Gelman B, Clifford D, Letendre S, Grant I, for the CHARTER Group. Peripheral nerve function in HIV-infection: electrophysiological and quantitative sensory test results in the CHARTER Study. American Academy of Neurology.
2010 Malvar J, Ellis R, Vaida F, Robinson-Papp J, Atkinson JH, Fan J, FitzSimons C, Collier A, McCutchan JA, McArthur J, Morgello S, Simpson D, Marra C, Gelman B, Clifford D, Letendre S, Grant I, for the CHARTER Group. Predictors of incident distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. International Society for NeuroVirology.
2010 Badiee J, Moore DJ, Vaida F, Franklin D, Gouaux B, McCutchan JA, Atkinson JH, Heaton RK, McArthur J, Morgello S, Simpson D, Collier A, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Suicidality and neuropsychological impairment in HIV-infected persons. International Neuropsychological Annual Meeting.
2010 Moore D, Arce M, Moseley S, McCutchan JA, Letendre SL, Vaida F, Achim CL, McArthur J, Morgello S, Simpson D, Gelman B, Collier A, Marra C, Clifford D, Grant I, the CHARTER Group, and the HNRC Group. The influence of family history of dementia on neuropsychological functioning among HIV infected persons across the lifespan. International Conference on HIV and Aging.
2009 Bharti AR, Letendre S, Wolfson T, Clifford D, Collier A, Gelman B, McArthur J, McCutchan A, Morgello S, Grant I. Clinical risk factors identify seronegative HCV co-infection in substantial minority of CHARTER participants. International Society for Neurovirology
2009 Best B, Letendre S, Capparelli E, Ellis R, Rossi S, Koopmans P, Grant I, and the CHARTER Group. Efavirenz and emtricitabine concentrations consistently exceed wild-type IC50 in cerebrospinal fluid: CHARTER findings. Conference on Retroviruses and Opportunistic Infections.
  2009 Heaton R, Franklin D, Clifford D, Woods SP, Rivera-Mindt M, Vigil O, Taylor M, Marcotte T, Atkinson JH, Grant I. HIV-associated Neurocognitive Impairment (NCI) Remains Prevalent in the Era of Combination Antiretroviral Therapy (CART): The CHARTER Study. Conference on Retroviruses and Opportunistic Infections.
2009 Ances B, Rosario D, Vaida F, Marquie-Beck J, Ellis R, Simpson D, Clifford D, McArthur J, McCutchan J, Grant I. Metabolic syndrome components as risk factors for distal sensory polyneuropathy: CHARTER findings. Conference on Retroviruses and Opportunistic Infections.
2009 McCutchan JA, Marquie-Beck J, Letendre S, Heaton R, Wolfson T, Rosario D, Alexander T, Marra C, Ances B, Grant I. Metabolic syndrome, diabetes, and cognitive impairment in the era of combination antiretroviral therapy. Conference on Retroviruses and Opportunistic Infections.
2009 Ellis RJ, Rosario D, Clifford D, McArthur J, Simpson D, Alexander TJ, Marra C, Gelman BB, Atkinson JH, Dworkin RH, Vaida F, Grant I. Neuropathic pain contributes to an excess of unemployment and disability in HIV infection: the CHARTER Study. International Society for Neurovirology.
2009 Heaton RK, Franklin DR, Clifford D, Woods SP, Mindt MR, Vigil OR, Taylor MJ, Marcotte TD, Atkinson JH, Grant I, and the CHARTER Group. Persistence and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: The CHARTER Study. International Society for Neurovirology.
2009 Letendre S, McClernon D, Ellis RJ, Munoz-Moreno J, Way L, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan A, Morgello S, Simpson D, Franklin D, Heaton R, Grant I, and the CHARTER Group. Persistent HIV in the central nervous system (CNS) during treatment is associated with worse antiretroviral therapy (ART) penetration and cognitive impairment. Conference on Retroviruses and Opportunistic Infections.
2009 Munoz-Moreno J, Letendre S, McClernon D, Ellis RJ, LeBlanc S, Rosario D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan A, Morgello S, Simpson D, Franklin D, Heaton RK, Grant I, and the CHARTER Group. Persistent HIV in the central nervous system during treatment is associated with worse antiretroviral therapy penetration and cognitive impairment. International Society for Neurovirology.
2009 Ellis R, Rosario D, Clifford D, McArthur J, Simpson D, Alexander T, Gelman B, Grant I. Persisting High Prevalence of HIV Distal Sensory Peripheral Neuropathy (DSPN) in the Era of Combination Antiretroviral Therapy (CART): Correlates in the CHARTER Study. Conference on Retroviruses and Opportunistic Infections.
  2009 Ellis R, Rosario D, Clifford D, McArthur JC, Simpson D, Alexander T, Gelman B, Collier A, Marra C, Ances B, Grant I. Prevalence, correlates and impact of neuropathic pain in HIV infection: the CHARTER Study. American Academy of Neurology. 
2009 Ellis RJ, Rosario D, Clifford D, McArthur J, Simpson D, Alexander T, Marra C, Morgello S, Gelman BB, Dworkin RH, Vaida F, Grant I. Risk factors for incident neuropathic pain in HIV infection: the CHARTER study. International Society for Neurovirology.
2009 Byrd D, Morgello S, Franklin D, Heaton R, Grant I. Substance use and HIV infection: Neurocognitive impact in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections.
  2008 Clifford DB, Kauwe JSK, Teshome M, Shah AR, Spinner ML, Morris JC, Holtzman DM, Fagan AM. Abnormal CSF Amyloid-beta 42 Levels Link HIV-Associated Cognitive Disease and Alzheimer's Disease. Conference on Retroviruses and Opportunistic Infections.
2008 Harrison TB, Schweinsburg BC, Jacobus J, Theilmann RJ, Taylor MJ, Woods SP, Gongvatana A, Franklin DR, Ellis RJ, Letendre SL, Heaton R, Frank L, Grant I, Jernigan T. Abnormal white matter signal and lower CD4 nadir independently predict lower white matter fractional anisotropy in HIV-infected individuals. International Neuropsychological Society Annual Meeting.
2008 Taylor MJ, Jernigan TL, Schweinsburg BC, Woods SP, Abramson IS, Clifford DB, Collier AC, Ellis RJ, Gamst AC, Gelman BB, Heaton RK, Letendre SL, Marcotte TD, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I. Frontal white matter and gray matter integrity measured by proton magnetic resonance spectroscopy predict different neuropsychological functions in HIV-infected individuals. International Neuropsychological Society Annual Meeting.
2008 Ellis R, Marquie-Beck J, Delaney P, Alexander T, Clifford D, McArthur J, Simpson D, Ake C, Collier A, Gelman B, and the CHARTER Group. HIV protease inhibitors and risk of peripheral neuropathy. Conference on Retroviruses and Opportunistic Infections.
2008 Jacobus J, Schweinsburg BC, Theilmann RJ, Taylor MJ, Woods SP, Harrison TB, Gongvatana A, Franklin DR, Letendre SL, Ellis RJ, Heaton RK, Frank LR, Grant I, Jernigan TL. Neurocognitive performance predicts altered white matter fractional anisotropy in HIV-infected individuals. International Neuropsychological Society Annual Meeting.
2008 Pillai S, Pasutti W, McCutchan JA, Marra C, Clifford D, Gelman B, Simpson D, McArthur J, Grant I, Wong J. Validation of a V3-based genetic biomarker of HIV-1 neurovirulence. Conference on Retroviruses and Opportunistic Infections.
2008 Jernigan TL, Archibald SL, Taylor MJ, Woods SP, Abramson I, Clifford D, Collier A, Ellis RJ, Gamst AC, Gelman BB, Heaton R, Letendre S, Marcotte T, Marra C, McArthur JC, McCutchen JA, Morgello S, Simpson D, Grant I. White matter damage and cortical volume loss affect different cognitive and motor functions in HIV-infected individuals. Journal of the International Neuropsychological Society, 14(Suppl. 1), 243.
2008 Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Franklin DR, Jernigan TL, Frank LR, Grant I. White matter tract injury and cognitive impairment in HIV-infected individuals. International Neuropsychological Society Annual Meeting.
2007 Henninger DE, Franklin D, Heaton RK, Morgello S, Rivera-Mindt M, and the CHARTER Group. A model of HIV infection, aging, neuropsychological and vocational functioning, and employment. American Academy of Clinical Neuropsychology.
  2007 Biswas B, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB, and the CHARTER Group.  Associations between adherence and neurocognitive performance among HIV-infected individuals: is near perfect adherence necessary? International Conference on HIV Treatment Adherence.
2007 Jernigan T, Letendre S, Archibald S, Clifford D, Collier A, Gelman B, MacArthur J. McCutchan J. Morgello S, Simpson D, Grant I, Ellis R, and the CHARTER Group. Chemokines in CSF are associated with white matter and cortical gray matter volumes in HIV-infected individuals. Conference on Retroviruses and Opportunistic Infections.
2007 Letendre S, Marquie-Beck J, Clifford D, Collier A, Gelman B,McArthur J, McCutchan J, Simpson D, Grant I, Ellis R, and the CHARTER Group. Clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. Conference on Retroviruses and Opportunistic Infections.
2007 Best BM, Letendre S, Rossi S, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Morgello S, Ellis R. Low exposure to Paroxetine and Sertraline, but not to Citalopram, Escitalopram and Fluoxetine in HIV-infected patients. Conference on Retroviruses and Opportunistic Infections.
2007 Letendre S, McClernon D, Benjamin R, Clifford D, Collier A, Gelman B, McArthurJ, McCutchan J, Morgello S, Ellis R, and the CHARTER Group. Presence of HIV RNA in cerebrospinal fluid that is undetectable with the ultrasensitive assay. Conference on Retroviruses and Opportunistic Infections.
  2007 Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Ake C, Clifford D, McArthur JC, Simpson D, Collier A, Gelman BB, McCutchan JA, Morgello S, Grant I, and the CHARTER Group. Use of protease inhibitors does not independently contribute to distal polyneuropathy in HIV infection. International Symposium on NeuroVirology.
2006 Henninger DE, Byrd D, Franklin D, Heaton RK, Morgello S, Rivera-Mindt M, and the CHARTER Group. Aging and HIV infection: the relationship between neuropsychological and vocational functioning. Scientific Meeting of the Gerontological Society of America.
2006 Wong J, Pillai S, Ellis R, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Morgello S, Grant I, and the CHARTER Group. Discordance of genotypic resistance between CSF and plasma virus in a multicenter observational cohort. Conference on Retroviruses and Opportunistic Infections.
2006 Best BM, Letendre S, Patel P, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Simpson D, Capparelli E. Low Atazanavir concentrations in cerebrospinal fluid. Conference on Retroviruses and Opportunistic Infections.